Adjuvax LLC — Department of Health and Human Services SBIR Phase I: 105
Adjuvax LLC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $600,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 105
- Solicitation
- PHS-2022-1
- NAICS
- —
- Place of performance
- AL
- Period
- —
Description
The contract supports the development of a saponin as a vaccine adjuvant. The adjuvant development activities are being conducted within the context of vaccines to protect against SARS-CoV-2 and pneumococcal infection.